These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 1633760)
1. [The long-term therapy of familial hypercholesterolemia with heparin-induced extracorporeal LDL precipitation]. Roth R; Köster W; Wanner C; Andre M; Orth M; Wieland H; Schollmeyer P Dtsch Med Wochenschr; 1992 Jul; 117(30):1135-41. PubMed ID: 1633760 [TBL] [Abstract][Full Text] [Related]
2. [Clinical long-term results of H.E.L.P.-apheresis]. Schuff-Werner P Z Kardiol; 2003; 92(Suppl 3):III28-9. PubMed ID: 14663598 [TBL] [Abstract][Full Text] [Related]
3. Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia. Jansen M; Banyai S; Schmaldienst S; Goldammer A; Rohac M; Hörl WH; Derfler K Wien Klin Wochenschr; 2000 Jan; 112(2):61-9. PubMed ID: 10703153 [TBL] [Abstract][Full Text] [Related]
4. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy]. Seidel D Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597 [TBL] [Abstract][Full Text] [Related]
5. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia]. Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396 [TBL] [Abstract][Full Text] [Related]
6. Treatment of severe hypercholesterolemia by heparin-induced extracorporeal LDL precipitation (HELP). Schuff-Werner P; Armstrong VW; Eisenhauer T; Thiery J; Seidel D Beitr Infusionsther; 1988; 23():118-26. PubMed ID: 2484765 [No Abstract] [Full Text] [Related]
7. [Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods]. Bláha V; Havel E; Zadák Z; Pidrman V; Bláha M; Kalinová M Vnitr Lek; 1995 Oct; 41(10):724-9. PubMed ID: 8578708 [TBL] [Abstract][Full Text] [Related]
8. Regression of coronary atherosclerosis and amelioration of renal function during LDL-immunoadsorption therapy in a renal transplant recipient. Jansen M; Gabriel H; Banyai S; Pidlich J; Weidinger F; Hörl WH; Derfler K Wien Klin Wochenschr; 1996; 108(14):425-31. PubMed ID: 8784984 [TBL] [Abstract][Full Text] [Related]
9. [Heparin-induced extracorporeal LDL precipitation (HELP) in therapy refractory hypercholesterolemia and coronary heart disease: effect on clinical and morphological regression of coronary sclerosis]. Schuff-Werner P Z Kardiol; 1997; 86 Suppl 1():57-64. PubMed ID: 9173722 [TBL] [Abstract][Full Text] [Related]
10. Long-term prevention of premature coronary atherosclerosis in homozygous familial hypercholesterolemia. Jaeger BR; Tsobanelis T; Bengel F; Schwaiger M; Seidel D J Pediatr; 2002 Jul; 141(1):125-8. PubMed ID: 12091863 [TBL] [Abstract][Full Text] [Related]
11. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)]. Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601 [TBL] [Abstract][Full Text] [Related]
12. Removal of cholesterol from blood by affinity binding to heparin-agarose: evaluation on treatment in homozygous familial hypercholesterolemia. Lupien PJ; Moorjani S; Lou M; Brun D; Gagné C Pediatr Res; 1980 Feb; 14(2):113-7. PubMed ID: 7360525 [TBL] [Abstract][Full Text] [Related]
13. HELP LDL-apheresis in two cases of familial hypercholesterolemic pregnant women. Anedda S; Mura S; Marcello C; Pintus P Transfus Apher Sci; 2011 Feb; 44(1):21-4. PubMed ID: 21257349 [TBL] [Abstract][Full Text] [Related]
15. Long term effect of LDL apheresis on coronary heart disease. Donner MG; Richter WO; Schwandt P Eur J Med Res; 1997 Jun; 2(6):270-4. PubMed ID: 9182655 [TBL] [Abstract][Full Text] [Related]
16. Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation. Lintott CJ; Scott RS; Sharpe DN; Nye ER; Charleson H; French JK; White HD; Reuben S; Maling TJ; Lewis GR Med J Aust; 1991 Oct; 155(7):433-6. PubMed ID: 1921811 [TBL] [Abstract][Full Text] [Related]
17. Long-term efficiency, biocompatibility, and clinical safety of combined simultaneous LDL-apheresis and haemodialysis in patients with hypercholesterolaemia and end-stage renal failure. Bosch T; Thiery J; Gurland HJ; Seidel D Nephrol Dial Transplant; 1993; 8(12):1350-8. PubMed ID: 8159304 [TBL] [Abstract][Full Text] [Related]
18. [Heparin-induced extracorporeal LDL precipitation (H.E.L.P.). A new therapeutic possibility in vascular occlusion of the retina--initial results]. Haas A; Walzl M; Faulborn J; Walzl B; Berglöff J; Eckhardt M Ophthalmologe; 1994 Jun; 91(3):283-7. PubMed ID: 8086743 [TBL] [Abstract][Full Text] [Related]
19. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial. Illingworth DR; Stein EA; Mitchel YB; Dujovne CA; Frost PH; Knopp RH; Tun P; Zupkis RV; Greguski RA Arch Intern Med; 1994 Jul; 154(14):1586-95. PubMed ID: 8031206 [TBL] [Abstract][Full Text] [Related]
20. Combination drug therapy for hypercholesterolemia. The trade-off between cost and simplicity. Heudebert GR; Van Ruiswyk J; Hiatt J; Schectman G Arch Intern Med; 1993 Aug; 153(15):1828-37. PubMed ID: 8333817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]